The advances in the prevention, diagnosis and treatment of cardiovascular disease will be the focus of a conference to take place in Dubai, UAE next month.

 

The fifth Annual Case Based Approach to Controversiers in Cardiovascular Disease Conference will run from October 8 to 10 at the Mohammed Bin Rashid Academic Medical Centre in Dubai Healthcare City, said a statement.

 

The conference, organised by Cleveland Clinic and Mayo Clinic in co-operation with Emirates Cardiac Society, has been accredited for 14 Continuous Medical Education hours from UAE University, it said.

 

All the topics will be presented in a 'real world' case-based format, which will encourage participation and debate among the faculty and attendees. 

 

The course directors and speakers will come from Mayo Clinic and Cleveland Clinic in the US, and will be joined by prominent physicians in the cardiovascular field from the UAE.

 

Walid Saliba, course director of the conference and cardiologist in Cleveland Clinic, US, said: “The conference will comprise valuable and up-to-date topics in the cardiovascular field that are relevant to the medical disciplines being addressed in the region. 

 

"Our team of speakers aims to share our knowledge and the recent updates with the conviction that this will allow healthcare professionals to take better care of their patients.  We’re proud to bring our expertise to the Middle East region, and specifically to the United Arab Emirates, in collaboration with the Mayo Clinic.”

 

The conference will host up to 300 attendees and is open to all health care professionals from the region who are involved in the management of patients with cardiovascular disease, including cardiologists, cardiac surgeons, internists, residents, fellows, physician assistants, nurses and other allied health professionals involved in the care of cardiovascular patients, said the statement.

 

It is also open for medical students with an interest in cardiothoracic surgery and cardiology.

 

The sessions will focus on cardiovascular diseases, electrophysiology, coronary artery disease, valvular disease, heart failure, and lipid management. 

 

Physicians will discuss real male and female patient cases from different age groups and different conditions. 

 

A satellite symposium will be dedicated to preventive cardiology and emerging therapies for dyslipidemia; and another one will focus on new developments for stroke prevention in atrial fibrillation. 

 

Several other sessions will focus on women and young pregnant women with heart problems and chest pain. One of the speakers will also give an update on a case about a patient with heart failure that was discussed during last year’s conference.

 

The speakers will assess the benefits and limitations of the current standard of care for the treatment of heart failure, and will discuss the wider applicability and potential impact of emerging percutaneous valve technology on the treatment of aortic stenosis and mitral regurgitation. 

 

They will also analyse the impact of gender differences in the management of cardiovascular diseases; review ventricular tachycardia storm, occurrence, management, and outcomes; summarise the current recommendations for the use of old and new anticoagulants and antiplatelet agents in atrial fibrillation; and develop a general understanding of who to refer for transcutaneous aortic valve replacement (TAVR), said the statement.

 

Alongside the conference, there will be an exhibit, providing attendees exposure to the most cutting-edge technologies, resources and treatment solutions in the field of cardiovascular medicine, it added. - TradeArabia News Service